Embecta Corp

NASDAQ EMBC

Download Data

Embecta Corp Long-Term Assets (Other) 3 year CAGR for the quarter ending March 31, 2024

Embecta Corp Long-Term Assets (Other) 3 year CAGR is NA for the quarter ending March 31, 2024. Long-Term Assets (Other) are long-term assets that are not classified under property, plant, equipment, intangible assets, or investments. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.
  • Embecta Corp Long-Term Assets (Other) for the quarter ending March 31, 2023 was USD 116.20 M, a 600.00% change year over year.
  • Embecta Corp Long-Term Assets (Other) for the quarter ending March 31, 2022 was USD 16.60 M.
NASDAQ: EMBC

Embecta Corp

CEO Mr. Devdatt Kurdikar
IPO Date April 1, 2022
Location United States
Headquarters 300 Kimball Drive, Parsippany, NJ, United States, 07054
Employees 2,200
Sector Healthcare
Industry Medical instruments & supplies
Description

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Similar companies

ANGO

AngioDynamics Inc

NA

NA

AKYA

Akoya Biosciences Inc

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email